A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression

References

• HirschfeldRMThe epidemiology of depression and the evolution of treatmentJ Clin Psychiatry201273Suppl 15922951236
   PubMedGoogle Scholar
• CravenMABlandRDepression in primary care: current and future challengesCan J Psychiatry201358844244823972105
   PubMed Web of Science ®Google Scholar
• World Health OrganizationDepression and Other Common Mental Disorders: Global Health EstimatesGenevaWHO2017
   Google Scholar
• World Health OrganizationDépression2018 Available from: http://www.who.int/mediacentre/factsheets/fs369/frAccessed February 28, 2018
   Google Scholar
• WittchenHUMühligSBeesdoKMental disorders in primary careDialogues Clin Neurosci20035211512822034245
   PubMedGoogle Scholar
• DemyttenaereKCompliance during treatment with antidepressantsJ Affect Disord199743127399127828
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry2006163111905191717074942
   PubMed Web of Science ®Google Scholar
• FournierJCDerubeisRJHollonSDAntidepressant drug effects and depression severity: a patient-level meta-analysisJAMA20103031475320051569
   PubMed Web of Science ®Google Scholar
• ZimmermannTMClouthJElosgeMPatient preferences for outcomes of depression treatment in Germany: a choice-based conjoint analysis studyJ Affect Disord20131482–321021923290792
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAntidepressants (tricyclic antidepressants and selective serotonin reuptake inhibitors) in treatment of adults with depression2010 Available from: http://www.who.int/mental_health/mhgap/evidence/depression/mh_evidence_profile_q1_tca_ssri_2010_en.pdfAccessed February 27, 2018
   Google Scholar
• Haute Autorité de SantéEpisode dépressif caractérisé de l’adulte: prise en charge en soins de premier recours2017 Available from: https://www.has-sante.fr/portail/upload/docs/application/pdf/2017-10/depression_adulte_recommandations_version_mel.pdfAccessed March 27, 2018
   Google Scholar
• National Institute for Health and Care ExcellenceDepression in Adults: Recognition and ManagementLondonNICE2009
   Google Scholar
• MitchellJTrangleMDegnanBAdult depression in primary care2013 Available from: http://pcptoolkit.beaconhealthoptions.com/wp-content/uploads/2016/02/ICSI_Depression.pdfAccessed March 27, 2018
   Google Scholar
• Michigan Quality Improvement ConsortiumPrimary care diagnosis and management of adults with depression2018 Available from: http://www.mqic.org/pdf/mqic_primary_care_diagnosis_and_management_of_adults_with_depression_cpg.pdfAccessed March 1, 2018
   Google Scholar
• AnthesEDepression: a change of mindNature2014515752618518725391944
   PubMed Web of Science ®Google Scholar
• WarrilowAEBeechBSelf-help CBT for depression: opportunities for primary care mental health nurses?J Psychiatr Ment Health Nurs200916979280319824973
   PubMed Web of Science ®Google Scholar
• NoorbalaAAAkhondzadehSTahmacebi-PourNJamshidiAHHydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trialJ Ethnopharmacol200597228128415707766
   PubMed Web of Science ®Google Scholar
• MoshiriEBastiAANoorbalaAAJamshidiAHAbbasiSHAkhondzadehSCrocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trialPhytomedicine2006139–1060761116979327
   PubMed Web of Science ®Google Scholar
• BastiAAMoshiriENoorbalaAAJamshidiAHAbbasiSHAkhondzadehSComparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trialProg Neuropsychopharmacol Biol Psychiatry200731243944217174460
   PubMed Web of Science ®Google Scholar
• HausenblasHASahaDDubyakPJAntonSDSaffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trialsJ Integr Med201311637738324299602
   PubMedGoogle Scholar
• MazidiMShemshianMMousaviSHA double-blind, randomized and placebo-controlled trial of saffron (Crocus sativus L.) in the treatment of anxiety and depressionJ Complement Integr Med201613219519927101556
   PubMedGoogle Scholar
• ShafieeMArekhiSOmranzadehASahebkarASaffron in the treatment of depression, anxiety and other mental disorders: current evidence and potential mechanisms of actionJ Affect Disord201822733033729136602
   PubMed Web of Science ®Google Scholar
• AkhondzadehSFallah-PourHAfkhamKJamshidiAHKhalighi-CigaroudiFComparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]BMC Complement Altern Med200441215341662
   PubMedGoogle Scholar
• AkhondzadehSTahmacebi-PourNNoorbalaAACrocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trialPhytother Res200519214815115852492
   PubMed Web of Science ®Google Scholar
• AmsterdamJDPanossianAGRhodiola rosea L. as a putative botanical antidepressantPhytomedicine201623777078327013349
   PubMed Web of Science ®Google Scholar
• YeungKSHernandezMMaoJJHavilandIGubiliJHerbal medicine for depression and anxiety: a systematic review with assessment of potential psycho-oncologic relevancePhytother Res201832586589129464801
   PubMed Web of Science ®Google Scholar
• BrichenkoVKupriyanovaISkorokhodovaTThe use of herbal adaptogens together with tricyclic antidepressants in patients with psychogenic depressionsGoldbergEDModern Problems of Pharmacology and Search for New MedicinesTomskTomsk University Press19865860
   Google Scholar
• BrichenkoVSkorokhodovaTHerbal Adaptogens in Rehabilitation of Patients with Depression: Clinical and Organisational Aspects of Early Manifestations of Nervous and Mental Diseases15BarnaulAltajskoe Kniže1987
   Google Scholar
• PerfumiMMattioliLAdaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in micePhytother Res2007211374317072830
   PubMed Web of Science ®Google Scholar
• DarbinyanVAslanyanGAmroyanEGabrielyanEMalmströmCPanossianAClinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depressionNord J Psychiatry200761534334817990195
   PubMed Web of Science ®Google Scholar
• World Health OrganizationMental and behavioural disordersInternational Statistical Classification of Diseases and Related Health Problems10th edGenevaWHO2016F00F99
   Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry1960231566214399272
   PubMed Web of Science ®Google Scholar
• MajMDevelopment and validation of the current concept of major depressionPsychopathology201245313514622399134
   PubMed Web of Science ®Google Scholar
• MaoJJXieSXZeeJRhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trialPhytomedicine201522339439925837277
   PubMed Web of Science ®Google Scholar
• CropleyMBanksAPBoyleJThe effects of Rhodiola rosea L. extract on anxiety, stress, cognition and other mood symptomsPhytother Res201529121934193926502953
   PubMed Web of Science ®Google Scholar
• OlssonEMvon SchéeleBPanossianAGA randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatiguePlanta Med200975210511219016404
   PubMed Web of Science ®Google Scholar
• AnghelescuIGEdwardsDSeifritzEKasperSStress management and the role of Rhodiola rosea: a reviewInt J Psychiatry Clin Pract Epub2018111
   Web of Science ®Google Scholar
• Basiri-MoghadamMHamzeiAMoslemARPasban-NoghabiSGhorbaniNGhenaatiJComparison of the anxiolytic effects of saffron (Crocus sativus. L) and diazepam before herniorrhaphy surgery: a double blind randomized clinical trialZahedan J Res Med Sci2016183e6248
   Google Scholar
• WuZFangYComorbidity of depressive and anxiety disorders: challenges in diagnosis and assessmentShanghai Arch Psychiatry201426422723125317009
   PubMedGoogle Scholar
• LamersFvan OppenPComijsHCComorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA)J Clin Psychiatry201172334134821294994
   PubMed Web of Science ®Google Scholar
• FavaMRushAJAlpertJEDifference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D reportAm J Psychiatry2008165334235118172020
   PubMed Web of Science ®Google Scholar
• ClaytonPJGroveWMCoryellWKellerMHirschfeldRFawcettJFollow-up and family study of anxious depressionAm J Psychiatry199114811151215171928465
   PubMed Web of Science ®Google Scholar
• FavaMUebelackerLAAlpertJENierenbergAAPavaJARosenbaumJFMajor depressive subtypes and treatment responseBiol Psychiatry19974275685769376453
   PubMed Web of Science ®Google Scholar
• FlintAJRifatSLAnxious depression in elderly patients: response to antidepressant treatmentAm J Geriatr Psychiatry1997521071159106374
   PubMed Web of Science ®Google Scholar
• DavidsonJRMeoniPHaudiquetVCantillonMHackettDAchieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptomsDepress Anxiety200216141312203668
   PubMed Web of Science ®Google Scholar
• SaveanuREtkinADucheminAMThe International Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatmentJ Psychiatr Res20156111225586212
   PubMed Web of Science ®Google Scholar
• TollefsonGDHolmanSLSaylerMEPotvinJHFluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious featuresJ Clin Psychiatry199455250598077155
   PubMed Web of Science ®Google Scholar
• RussellJMKoranLMRushJEffect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depressionDepress Anxiety2001131182711233456
   PubMed Web of Science ®Google Scholar
• LeuchtSFennemaHEngelRKaspers-JanssenMLeppingPSzegediAWhat does the HAMD mean?J Affect Disord20131482–324324823357658
   PubMed Web of Science ®Google Scholar
• ForkmannTSchererABoeckerMPawelzikMJostesRGauggelSThe Clinical Global Impression scale and the influence of patient or staff perspective on outcomeBMC Psychiatry2011118321569566
   PubMed Web of Science ®Google Scholar
• GastparMSingerAZellerKComparative efficacy and safety of a once-daily dosage of Hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled studyPharmacopsychiatry2006392667516555167
   PubMed Web of Science ®Google Scholar
• RampakakisESte-MariePASampalisJSKarellisAShirYFitzcharlesMAReal-life assessment of the validity of patient global impression of change in fibromyalgiaRMD Open201511e00014626535150
   PubMed Web of Science ®Google Scholar
• BystritskyAKerwinLFeusnerJDA pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD)J Altern Complement Med200814217518018307390
   PubMed Web of Science ®Google Scholar
• LoprestiALDrummondPDSaffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of actionHum Psychopharmacol201429651752725384672
   PubMed Web of Science ®Google Scholar